Before Silicon Valley was all apps and ad tech, it was about atoms—not just bits. The future of innovation depends on ...

State tip lines have been targets for spam and personal grievances. They've also had a chilling effect on classroom ...

An earlier version of this article incorrectly identified Scott Colter as leader of the Center for Baptist Leadership. In ...

Covering one company so tenaciously for so long is not common in tech journalism. What keeps me coming back is Microsoft’s ...

In this world of influencers, there’s something reassuring about the idea that so much R&D is being done to draw people ...

Modern science wouldn’t exist without the online research repository known as arXiv. Three decades in, its creator still ...

CT REIT has 6.4% dividend yield, strong Canadian Tire ties, and solid financials. See more on CTRRF's growth potential as ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Morgans analyst Scott Power notes there's a risk-off sentiment among investors as ASX health stocks fall again this week.

Families and students are growing nervous about the fate of the Free Application for Federal Student Aid (FAFSA) amid ...

AstraZeneca's IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

Diversity, equity and inclusion has become highly politicized — and there’s no standard definition for what it is.